Advertisement

Topics

Servier, Transgene partner to apply viral vectorization technology

13:49 EDT 29 Jun 2017 | CentreWatch

Servier and Transgene, a biotechnology company that designs and develops immunotherapies based on viral vectors, announced the signature of a research agreement on the application of viral vectorization technology for the production of allogenic CAR-T cell therapies. The aim is to obtain more efficient products for patients. “Allogenic cell therapies using CAR-T open a major […]

The post Servier, Transgene partner to apply viral vectorization technology appeared first on CenterWatch News Online.

Original Article: Servier, Transgene partner to apply viral vectorization technology

NEXT ARTICLE

More From BioPortfolio on "Servier, Transgene partner to apply viral vectorization technology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...